MDSAP

Establishment Labs Launches Motiva Flora Tissue Expander in Europe and Other CE Mark Countries

Retrieved on: 
Thursday, September 2, 2021
Oncology, Medical Devices, Health, Consumer, Surgery, Women, Private Securities Litigation Reform Act, Form 10-K, Securities Act of 1933, IDE, U.S. Securities and Exchange Commission, Partnership, RFID, Breast reconstruction, Annual report, Security (finance), Surgeon, Time, Drug Quality and Security Act, MRI, Diversified Specialty Institute Holdings, Inc., Environment, Securities Exchange Act of 1934, Establishment, Risk, FDA, Woman, Adoption, Clinical trial, 21 CFR 820, MDSAP, ESTA, Goal, Motiva, NASDAQ, Medical device, Medical imaging

Other participants on the panel included reconstructive surgeons with experience using Motiva Flora and members of the medical and scientific advisory boards of Establishment Labs.

Key Points: 
  • Other participants on the panel included reconstructive surgeons with experience using Motiva Flora and members of the medical and scientific advisory boards of Establishment Labs.
  • In Europe, breast reconstruction represents 20% or more of the breast implant market, added Juan Jos Chacn-Quirs, Founder and Chief Executive Officer of Establishment Labs.
  • The Motiva Flora tissue expander offers several notable innovations, including Establishment Labs patented SmoothSilk surface technology as well as an RFID-enabled, non-magnetic integrated port, that offer potential improvements in imaging, treatment, and overall clinical outcomes and patient satisfaction.
  • The Motiva Flora tissue expander is currently not approved for commercial distribution in the United States.

TÜV SÜD and Infosec Bring Hands-On Technical Cybersecurity Training to Employees Worldwide

Retrieved on: 
Tuesday, August 31, 2021
Education, Security, Technology, Networks, Internet, Training, UN, IOT, ISO 13485, Instagram, InfoSec Institute, Academy, Knowledge, Efficiency, ISO 14001, Mobility, Awareness, Safety, Partnership, Solution, PCI-DSS, Blog, Union, Computer security, Software, Health care, European Union Agency for Cybersecurity, Botswana Private Medical & Health Services Workers' Union, ISO, EU, MITRE, NIST, Environment, CEO, Maritime Industrial Services, Twitter, MDSAP, Information security, GDPR, ATT, IEC, LinkedIn, IEC 62443, Organization, FDA, Matrix, EMC, Workforce, Certification, Product-service system, Pressure, Medicine, Versata Development Group, Inc. v. SAP America, Inc., MDR, ISO 9001, News, Â, Risk management, TÜV SÜD, TÜV SÜD America, Infosec, TÜV SÜD, TÜV SÜD AMERICA, INFOSEC

TV SD announces its partnership with Infosec Institute, the leading cybersecurity education provider, to offer Infosecs award-winning cyber technical skill development platform and bootcamps to their worldwide network of expert technology sales partners.

Key Points: 
  • TV SD announces its partnership with Infosec Institute, the leading cybersecurity education provider, to offer Infosecs award-winning cyber technical skill development platform and bootcamps to their worldwide network of expert technology sales partners.
  • TV SD provides customers and partners worldwide a comprehensive portfolio of testing, certification, auditing and advisory services.
  • Were proud to partner with TV SD to equip even more organizations and professionals with the technical knowledge, skills and confidence to outsmart cybercrimals, said Jack Koziol, Infosec CEO and founder.
  • TV SD is a premium quality, safety, and sustainability solutions provider that specialises in testing, inspection, auditing, certification, training, and knowledge services.

BioElectronics Corporation Discusses Q2 Financials

Retrieved on: 
Monday, August 30, 2021
Company, Certification, MDSAP, U.S. Securities and Exchange Commission, Surgeon, GLOBE, SEC, Small business, Amazon (company), Social media, Small Business Administration, CE, CVS, BIEL, Forgiveness, Forward-looking statement, OTC, EME, CEO, KT, Sale, Bioelectronics, OTC Markets Group, Athlete, Technology, Security (finance), Audit

FREDERICK, MARYLAND, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) said today that it would like to clarify information about the Company and acknowledge the investor community’s request for comments following Q2 financials.

Key Points: 
  • FREDERICK, MARYLAND, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation ( https://www.bielcorp.com/ OTC: BIEL) said today that it would like to clarify information about the Company and acknowledge the investor communitys request for comments following Q2 financials.
  • Key facts from the Q2 financials many of which were found in the footnotes:
    The CEO again took no pay, and the Chairman invested additional cash into the Company.
  • Products using BIEL technology are now on the shelves of major retailers including CVS and Walgreens.
  • While Q2 2021 sales were lower than Q1 2021 sales, this does not account for deferred revenue from booked orders, that amounts to $555,000.

One Day Webinar: Medical Device Single Audit Program Implementation & Participating Country Regulatory Processes: Focus on U.S., Canada, Brazil, Australia and Japan (September 28, 2021) - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 24, 2021
Medical Devices, Health, MDSAP, Program, Organization, Movement, Time, Safety, Medical device, Patient, Health Canada, GMP

The "Medical Device Single Audit Program [MDSAP] Implementation & Participating Country Regulatory Processes: U.S., Canada, Brazil, Australia and Japan" training has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Medical Device Single Audit Program [MDSAP] Implementation & Participating Country Regulatory Processes: U.S., Canada, Brazil, Australia and Japan" training has been added to ResearchAndMarkets.com's offering.
  • One such example is the Medical Device Single Audit Program [MDSAP], where Authorized Organizations would be allowed to carry out a single GMP audit on medical device manufacturing facilities and have it stand to support registrations across the current participating member countries: U.S. Canada, Brazil, Australia and Japan.
  • webinar is focused on understanding the Medical Device Single Audit Program, the scope of the program, how to apply, the Authorized Organizations, the rating system developed and what you can expect when signing onto the program.
  • Highlights of the key Regulatory Requirements for Medical Devices will also be covered for the participating MDSAP Countries of: U.S., Canada, Brazil, Australia and Japan.

Establishment Labs to Launch Motiva Flora Tissue Expander at London Breast Meeting on September 2, 2021

Retrieved on: 
Friday, August 20, 2021
Surgery, Medical Devices, Women, Consumer, Health, Private Securities Litigation Reform Act, Securities Exchange Act of 1934, Annual report, Program, MDSAP, Securities Act of 1933, ESTA, Adoption, U.S. Securities and Exchange Commission, RFID, Establishment, Time, Motiva, Risk, Clinical trial, NASDAQ, Goal, Environment, IDE, 21 CFR 820, Q&A, FDA, Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., Security (finance), Form 10-K, Pharmaceutical industry, Risk management

The symposium will feature members of the medical and scientific advisory boards of Establishment Labs and reconstructive surgeons who participated in the earlier limited launch of Motiva Flora.

Key Points: 
  • The symposium will feature members of the medical and scientific advisory boards of Establishment Labs and reconstructive surgeons who participated in the earlier limited launch of Motiva Flora.
  • In addition, members of Establishment Labs management team will outline the potential market opportunity and commercialization plans for Motiva Flora.
  • The symposium is part of the official program of the 2021 London Breast Meeting and will be held on Thursday, September 2 at 3pm BST.
  • The Motiva Flora tissue expander is currently not approved for commercial distribution in the United States.

Incorta Partners with MDSap to Expand Global Go-To-Market

Retrieved on: 
Tuesday, June 8, 2021
Technology, Retail, Manufacturing, Supply chain management, Online Retail, Other Technology, Software, Networks, Internet, Hardware, Other Manufacturing, Electronic design automation, Data management, Security, Articles, Business, Computing, Business software, Business intelligence, Analytics, Big data, SAP, Incorta, MDSap, Midis Group, INCORTA, MDSAP, MIDIS GROUP

Were thrilled to partner with Incorta to bring their state-of-the-art data analytics solution to our enterprise customers, said Tony Achkar, group managing director of MDSap.

Key Points: 
  • Were thrilled to partner with Incorta to bring their state-of-the-art data analytics solution to our enterprise customers, said Tony Achkar, group managing director of MDSap.
  • Incorta is allowing them to analyze their data at a level of speed and scale theyve never seen before.
  • As SAPs gold partner, MDSap leverages SAP technology and other solution providers to help businesses run smoothly and efficiently.
  • The Middle East presents exciting opportunities for digital transformation and growth, especially in the data analytics market, said Incorta CEO Scott Jones.